Biotech | May 12, 2022
Mawi DNA Technologies launches NextSWAB for Covid-19 test results
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing
With launches, continuing momentum in India, other branded markets and a pick-up in the US, Ajanta would deliver 12% revenue/PAT growth each over FY22-24
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
The capex for FY22 stood at Rs 145 crore and is expected to be in the range of Rs 250-350 crore for the entire FY23 which would be funded through a mix of internal accruals and debt
NWSS works with public health departments across the country to track SARS-CoV-2 levels in wastewater so communities can act quickly to prevent the spread of Covid-19.
Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
The company is preparing the response to the observations, which will be submitted to the USFDA within 15 business days
Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Subscribe To Our Newsletter & Stay Updated
